Focus Partners Wealth
DTIL icon

Focus Partners Wealth’s Precision BioSciences DTIL Stock Holding History

Focus Partners Wealth’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Hold
19,111
– – ﹤0.01% 2563
2026
Q1 		$105K Buy
+19,111
New +$88.2K ﹤0.01% 2505

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Focus Partners Wealth's DTIL Position: Q2 2026 in Review

Focus Partners Wealth held its Precision BioSciences (DTIL) position steady in Q2 2026 at 19,111 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #2563.

Focus Partners Wealth first reported a position in DTIL in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Focus Partners Wealth held 19,111 shares of Precision BioSciences worth $150K as of Q2 2026.
  • Focus Partners Wealth left its Precision BioSciences share count unchanged in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2563 holding.
  • Focus Partners Wealth first reported a position in Precision BioSciences in Q1 2026 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.